Literature DB >> 10669123

Prevalence of antibodies to hepatitis A among children and adolescents in Larnaca area, Cyprus.

A Hadjipanayis1, C Hadjichristodoulou, M Kallias, K Sava, A Petsa, K Demetriadou, C Christodoulou, A Constantinou, M Sidera.   

Abstract

The prevalence of antibodies to hepatitis A virus was investigated in 385 children and adolescents (52.2% males), aged 6 to 18, in the Larnaca area of Cyprus. This is the first study investigating the prevalence of hepatitis A in Cyprus for this age group. The population was stratified into two groups: 6 to 12 years old and 13 to 18 years old. None of the subjects in the first group were positive. The prevalence of hepatitis A in the age of group 13 tol8 was 1.6%. In conclusion, the low prevalence of anti-HAV demonstrates the susceptibility of young Cypriots to hepatitis A. This is a cause for concern as these unprotected young adults are frequently exposed to potentially infected individuals.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10669123     DOI： 10.1023/a:1007680310138

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  10 in total

1.  Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece.

Authors:  C Lionis; E Frangoulis; M Koulentakis; E Biziagos; E Kouroumalis
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

2.  Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy.

Authors:  T Stroffolini; M Chiaramonte; E Franco; M Rapicetta; D De Mattia; I Mura; R Trivello; A Giammanco; G Rigo; B Scarpa
Journal:  Infection       Date:  1991 Mar-Apr       Impact factor: 3.553

3.  An outbreak of hepatitis A in young adults in central Italy.

Authors:  T Stroffolini; W Biagini; L Lorenzoni; G P Palazzesi; M Divizia; R Frongillo
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

4.  Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents.

Authors:  A Gil; A González; R Dal-Ré; P Ortega; V Dominguez
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

Review 5.  Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases.

Authors: 
Journal:  Pediatrics       Date:  1996-12       Impact factor: 7.124

6.  Falling incidence and prevalence of hepatitis A in northern Spain.

Authors:  E Perez-Trallero; G Cilla; M Urbieta; M Dorronsoro; F Otero; J M Marimon
Journal:  Scand J Infect Dis       Date:  1994

7.  Epidemiology of hepatitis A in Mediterranean countries.

Authors:  G Papaevangelou
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

8.  Adult use of hepatitis A vaccine in developed countries.

Authors:  W Jilg
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

9.  [Seroepidemiology of hepatitis A in six departments in West-Central France in 1991].

Authors:  F Dubois; C Thevenas; E Caces; S Vol; A Doctoriarena; J L Ecault; A Goudeau; J Tichet
Journal:  Gastroenterol Clin Biol       Date:  1992

10.  Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region.

Authors:  O Weiland; J V Berg; E Bäck; P Lundbergh
Journal:  Infection       Date:  1979       Impact factor: 3.553
  10 in total
  1 in total

1.  The Lifestyle Profile of Individuals with Cardiovascular and Endocrine Diseases in Cyprus: A Hierarchical, Classification Analysis.

Authors:  Maria Kyprianidou; Demosthenes Panagiotakos; Konstantinos C Makris; Maria Kambanaros; Costas A Christophi; Konstantinos Giannakou
Journal:  Nutrients       Date:  2022-04-08       Impact factor: 6.706
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.